FDA Inspection 1162919 — CSL Plasma Inc.
The FDA completed an inspection of CSL Plasma Inc. on Feb 16, 2022 in Lackawanna, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 16, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lackawanna, NY (United States)